Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0507A in Glaucoma and Ocular Hypertension
NCT00449956Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of dorzolamide, timolol in Glaucoma, ocular hypertension, sponsored by Merck & Co.. Started Mar 2007; status: completed.
02
Drugs
dorzolamidetimolol
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00449956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449956.